Page 2 - சுயாதீனமான தகவல்கள் கண்காணிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Quantum Genomics Will Present Top-line Results From its QUORUM Study of Firibastat in Heart

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Quantum Genomics Will Present Top-line Results From its QUORUM Study of Firibastat in Heart . Quantum GenomicsApril 21, 2021 GMT PARIS, April 21, 2021 (GLOBE NEWSWIRE) Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult-to-treat and resistant hypertension and heart failure, will present top-line results from its QUORUM study of firibastat in heart failure post myocardial infarction at the European Society of Cardiology (ESC) meeting in August 2021. These results will also be published in a peer-review journal.

New yorkUnited statesFrance generalUnited kingdomGilles montalescotCatherine llorens cortesMike tattoryFrance french national institute of healthData monitoring committeeScientific centre for national researchDescartes universityScientific communicationsEuropean society of cardiologyEuropean society congressEuronext growthEuropean society

QUANTUM GENOMICS: Quantum Genomics will Present Top-line Results from its QUORUM study of Firibastat in Heart Failure post Myocardial Infarction at the European Society of Cardiology (ESC) Meeting

QUANTUM GENOMICS: Quantum Genomics will Present Top-line Results from its QUORUM study of Firibastat in Heart Failure post Myocardial Infarction at the European Society of Cardiology (ESC) Meeting
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesFrance generalUnited kingdomGilles montalescotCatherine llorens cortesMike tattoryFrance french national institute of healthData monitoring committeeScientific centre for national researchDescartes universityScientific communicationsEuropean society of cardiologyEuropean society congressQuantum genomicsEuronext growth

GlaxoSmithKline Discontinues Feladilimab Cancer Trials

GlaxoSmithKline Discontinues Feladilimab Cancer Trials
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomData monitoring committeeIndependent data monitoringநகரம் ஆஃப்ஒன்றுபட்டது கிஂக்டம்தகவல்கள் கண்காணிப்பு குழுசுயாதீனமான தகவல்கள் கண்காணிப்பு

Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19

Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United kingdomSouth africaCity ofSouth africanVir biotechnology incDrug administrationData monitoring committeeIndependent data monitoringEfficacy trialCare earlyEmergency use authorizationBiologics license applicationஒன்றுபட்டது கிஂக்டம்நகரம் ஆஃப்வீர் உயிரி தொழில்நுட்பவியல் இன்க்தகவல்கள் கண்காணிப்பு குழு

AstraZeneca: IDMC Recommends Primary Analysis For OlympiA Phase III Trial

LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L, AZN) said the OlympiA phase III trial for AstraZeneca and MSD's Lynparza will move to early primary analysis and reporting following a recommendation

City ofUnited kingdomData monitoring committeeIndependent data monitoringIndependent data monitoring committeeநகரம் ஆஃப்ஒன்றுபட்டது கிஂக்டம்தகவல்கள் கண்காணிப்பு குழுசுயாதீனமான தகவல்கள் கண்காணிப்புசுயாதீனமான தகவல்கள் கண்காணிப்பு குழு